Skip to Main Content

Paper Details

Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fraction.
Clin Chim Acta
6
2020
Author NameAffiliation
Hongsheng GuiCenter for Individualized and Genomic Medicine Research, Henry Ford Hospital
James McCordHeart and Vascular Institute
  • 1 - 2

Datasets

Release 1.2